Lactam-containing compounds and derivatives thereof as factor xa inhibitors

Details for Australian Patent Application No. 2008207537 (hide)

Owner Bristol-Myers Squibb Company

Inventors Pinto, Donald; Li, Yun-Long; Quan, Mimi; Han, Wei; Orwat, Michael; Lam, Patrick; Qiao, Jennifer; Koch, Stephanie

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2008207537

Parent 2002341693

Filing date 26 August 2008

Wipo publication date 18 September 2008

Acceptance publication date 4 November 2010

International Classifications

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/437 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 September 2008 Complete Application Filed

18 September 2008 Application Open to Public Inspection

  Published as AU-B-2008207537

4 November 2010 Application Accepted

  Published as AU-B-2008207537

3 March 2011 Standard Patent Sealed

8 December 2011 Corrigenda

  Applications Accepted - Name Index Under the name Bristol-Myers Squibb Company, Application No. 2008207537, under INID (54) correct the title to read Lactam-containing compounds and derivatives thereof as factor Xa inhibitors

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008207538-Using selective antagonists of persistent sodium current to treat neurological disorders and pain

2008207536-System and method for joint resurface repair